Editorial Comment from Dr Chen to Reduction of prostate cancer incidence by naftopidil, an α1-adrenoceptor antagonist and transforming growth factor-β signaling inhibitor
2013 ◽
Vol 20
(12)
◽
pp. 1220-1227
◽
1989 ◽
Vol 62
(1)
◽
pp. 79-87
◽
1993 ◽
Vol 47
(1-6)
◽
pp. 137-142
◽
2009 ◽
Vol 69
(17)
◽
pp. 7111-7120
◽